MxM News
Investigating Biden’s last minute pardons

MxM News
Quick Hit:
Ed Martin, the outgoing interim U.S. Attorney for the District of Columbia, has launched an investigation into the extraordinary scope of last-minute pardons issued by former President Joe Biden.
Key Details:
- Ed Martin told Vince Coglianese that Biden’s pardons are under review due to their unusual scope and timing.
- Among those pardoned were Hunter Biden, James and Frank Biden, and members of the January 6 committee including Reps. Liz Cheney and Adam Kinzinger.
- Martin is questioning whether the use of the president’s plenary pardon power in this context rises to the level of corruption.
Diving Deeper:
Ed Martin’s remarks during an interview with Daily Caller’s Vince Coglianese signal a potentially explosive inquiry into the Biden administration’s final acts before relinquishing power. The investigation centers around what Martin called “suspiciously specific” pardons that were issued in a sweeping, preemptive manner to shield political allies and family members from future legal consequences.
Martin pointed to historical precedent to highlight the seriousness of the issue, referencing Bill Clinton’s infamous pardon of fugitive financier Marc Rich. While that move was widely criticized, it ultimately didn’t lead to criminal consequences due to the president’s expansive constitutional authority. Martin suggested that Biden’s pardons may go beyond even that level of abuse.
“What’s different here,” Martin explained, “is that the pardons were broad, yet highly targeted in timing. Some went back 14 years and covered everything the individuals had done during that period.” He added, “That leads to questions—because while the plenary power is real, it doesn’t exempt the motive from scrutiny.”
Hunter Biden’s pardon stands out among the most controversial. Despite vowing publicly for months that he would not intervene in his son’s legal troubles, Joe Biden issued a full pardon on Dec. 1, 2024, covering Hunter’s activities from Jan. 1, 2014, to Dec. 1, 2024. This sweep includes matters tied to Hunter’s overseas business dealings, his illegal gun purchase conviction, and an ongoing federal indictment involving over $1.4 million in unpaid taxes.
The pardon of Biden’s brother James, also linked to Hunter’s foreign business interests, and Frank Biden, who exploited his brother’s 2021 inauguration to promote his Florida law firm, have further fueled accusations of self-dealing.
Perhaps most egregiously, Biden issued blanket pardons to former Reps. Liz Cheney and Adam Kinzinger—Republican members of the now-defunct January 6 Select Committee. This preemptive move gave them full immunity for any actions related to their controversial investigations and public statements surrounding the Capitol unrest of January 6, 2021.
As Martin put it, “The question is: what is going on here?” His team has begun receiving responses to inquiries, and while no formal charges have been announced, the investigation appears to be ongoing.
International
Bongino announces FBI will release files on COVID cover up, Mar-a-Lago Raid and more

MxM News
Quick Hit:
FBI Deputy Director Dan Bongino announced that the bureau will begin releasing information on a number of controversial investigations long shielded from public view.
Key Details:
- Bongino said the FBI is clearing information on high-profile cases, including COVID, Crossfire Hurricane, and the Trump Mar-a-Lago raid.
- The bureau is actively working with the DOJ on releasing Epstein case details and cracking down on child sexual abuse content.
- Bongino dismissed media attacks on FBI Director Kash Patel as “verifiable lies” and accused the press of fabricating stories.
Diving Deeper:
FBI Deputy Director Dan Bongino disclosed on Saturday that the bureau will begin releasing information previously kept under tight wraps, including cases that many Americans believe were swept under the rug for political or institutional protection.
Bongino, a former NYPD officer, Secret Service agent, and outspoken conservative commentator, took to X to announce that his office has already started cooperating with Congress and the public by providing long-requested information. Among the cases he cited: the attempted assassination of Rep. Steve Scalise, the Nashville Christian school shooting, the Crossfire Hurricane probe, and the COVID-19 origins and cover-up.
“This isn’t business as usual anymore,” Bongino wrote. “We’re clearing information to Congress, and the public, as quickly as possible.”
One of the most politically explosive revelations relates to the FBI’s handling of the Mar-a-Lago raid, an unprecedented move to search the home of the sitting president’s top political opponent, President Donald Trump. Bongino’s announcement signals that internal communications and case files may soon be scrutinized by congressional investigators and the public alike.
Bongino also confirmed that the agency is working closely with the DOJ on the Epstein case, noting the overwhelming volume of child sexual abuse material that must be reviewed. He emphasized that protecting children remains a core mission of the FBI under his and Director Kash Patel’s leadership.
“Operation ‘Restoring Justice,’ where we locked up child predators and 764 subjects, in every part of the country, is just the beginning,” he wrote. “Think twice if you’ve targeted children, because you’re next.”
The deputy director didn’t hold back in pushing back against media reports that characterized Patel’s leadership as unserious or performative. “The media continue to entirely fabricate stories,” Bongino wrote, describing reports about Patel skipping briefings and attending sports events as “a verifiable lie.”
He defended Patel’s work ethic, noting that the FBI director routinely works 10–12 hour days and meets with top counter-terror officials and global law enforcement partners.
Business
U.S., China agree to 90-day tariff reduction after negotiations

MxM News
Quick Hit:
The United States and China have agreed to reduce tariffs for 90 days following trade negotiations in Geneva, offering temporary relief to global markets. The deal marks a pause in the escalating economic conflict, with both countries pledging to resume talks during the truce.
Key Details:
- The U.S. will lower tariffs on Chinese imports from April levels by 24 percentage points, maintaining a 10% base rate.
- China will implement a matching reduction and suspend additional non-tariff measures targeting American goods.
- S&P 500 futures jumped 3%, while U.S. bond yields climbed as investors reacted to signs of de-escalation.
🚨 Treasury Secretary @SecScottBessent announces a major trade deal with China:
“We have reached an agreement on a 90-day pause and substantially move down the tariff levels. Both sides on the reciprocal tariffs will move their tariffs down 115%.” pic.twitter.com/d89RFR3jA4
— Trump War Room (@TrumpWarRoom) May 12, 2025
Diving Deeper:
After weeks of mounting economic tension, the United States and China on Monday jointly announced a 90-day reduction in tariffs, signaling a temporary easing of the trade war that has unnerved businesses, investors, and policymakers across the globe.
The agreement, reached during weekend negotiations in Geneva, was confirmed by U.S. Treasury Secretary Scott Bessent. “We had very robust discussions. Both sides showed great respect to what was a very positive process,” Bessent said in remarks to reporters. According to Bessent, the U.S. will lower its tariffs to 30%, while China will cut its rates to 10% during this period—a proportional rollback from their respective April highs.
The White House clarified that the reduction affects tariffs announced by President Trump on April 2, cutting them by 24 percentage points while keeping the base ad valorem rate of 10%. In response, Beijing agreed not only to match the tariff rollback but also to lift administrative barriers and non-tariff measures it had imposed since April.
Both countries are expected to implement the agreed measures by Wednesday. The joint statement released following the talks indicated that discussions will continue over the coming months as the two sides explore a longer-term resolution.
Markets reacted quickly and positively. S&P 500 futures surged over 3% on the news, providing a shot of optimism after weeks of uncertainty. The U.S. Dollar Index, which had been under pressure due to investor anxiety about America’s trade posture, rose more than 1%. Meanwhile, bond markets adjusted sharply, with the yield on the 10-year Treasury climbing to 4.445%, its highest point since early April.
While the 90-day pause offers breathing room, the underlying issues remain unresolved. Businesses that had delayed orders due to tariff costs may now rush to restock, a move that could cause short-term volatility or even a demand shock in some sectors. Economists warn that without a longer-term agreement, the reprieve may prove fleeting.
For now, though, the breakthrough offers a glimmer of hope. It’s a notable win for President Trump’s strategy of tough negotiations, underscoring his administration’s commitment to putting American interests first while forcing adversaries to the table. The outcome stands in stark contrast to the previous administration’s conciliatory tone and may reinforce the argument for a more assertive U.S. economic posture on the world stage.
-
Business2 days ago
The ESG Shell Game Behind The U.S. Plastics Pact
-
espionage24 hours ago
Pro-Beijing Diaspora Group That Lobbied to Oust O’Toole Now Calls for Poilievre’s Resignation Amid PRC Interference Probes
-
Agriculture17 hours ago
Canada Greenlights Mass Culling of 400 Research Ostriches Despite Full Recovery from Bird Flu Months Ago
-
espionage18 hours ago
Ottawa Raises Alarm With Beijing Over Hong Kong Detention of CPC Candidate Joe Tay’s Family
-
COVID-192 days ago
Freedom Convoy leader Tamara Lich to face sentencing July 23
-
International2 days ago
Bongino announces FBI will release files on COVID cover up, Mar-a-Lago Raid and more
-
Health2 days ago
Trump signs executive order aiming to slash prescription drug costs up to 90%
-
Health24 hours ago
Trump’s surgeon general pick is a threat to Big Pharma, not medical freedom